AIFF Firefly Neuroscience, Inc. Total Business Assets
Firefly Neuroscience, Inc (AIFF) possesses significant market influence through the implementation of AI standards, rendering the demand for its diagnostics highly resilient. However, the slow adoption of brain mapping systems by physicians and operational losses are straining capital. This chart reflects an asset value of 15.86, illustrating the resources of a business that generates revenue from cloud-based software for analyzing brain activity in anxiety disorders.
Analytical breakdowns and data insights for company Firefly Neuroscience Inc (AIFF)
- current price and projected stock value:
- market capitalization data:
- book capitalization information:
- debt burden and liquidity indicators:
All Debt to Shareholders' Equity Ratio Firefly Neuroscience, Inc|AIFF - Long-Term Debt to Equity|Current Liabilities to Capital Firefly Neuro|AIFF - Company Aggregate Debts|Debts to Book Capitalization Ratio AIFF|AIFF - Company Long-Term Debts|Short-Term Debt Volume Firefly Neuroscience|Intermediate Coverage Ratio fireflyneuro.com
- company profitability and valuation multiples indicators:
Fundamental valuation:fireflyneuro.com AIFF
Total assets, reverse-calculated via ROA, reflect the company's aggregate resource base, allowing investors to differentiate real capitalization growth from speculative fluctuations through gross asset dynamics. The steady expansion of this mass confirms the financial stability of Firefly Neuroscience, Inc (AIFF), supporting the development of the innovative Brain Network Analytics AI platform for high-precision monitoring of neurological pathologies.
Direct competitors
Total Asset Value of Company BIIB (biogen.com)|Aggregate Company Assets Neurocrine Biosciences, Inc.|Total Business Assets RGC (Regencell Bioscience Ltd)|Company Total Assets AXSM|ACAD - Company Assets|Xenon Pharmaceuticals - Cumulative Company Assets|Company Total Assets vikingtherapeutics.com VKTX|SUPN - Aggregate Company Assets|Aggregate Asset Value CPRX (Catalyst Pharma)|Denali Therapeutics Inc (DNLI) - Aggregate Company Assets|Company Assets Harmony Corp (HRMY)|BHVN (Biohaven Ltd.) - Company Total Assets|amylyx.com - Total Asset Value of Company|Company Total Assets TRVI|Company Total Asset Base Praxis Precision Medicines Inc|Aggregate Company Assets Anavex Corp AVXL|Aggregate Asset Value CBLL|Prothena Corporation plc - Company Total Assets|Company Assets Alector, Inc.|ANNX: Company Total Assets|Total Asset Value of Company OMER (Omeros)|Aggregate Company Assets Neurogene Corp|Aggregate Company Assets ACIU|Cumulative Company Assets VYGR (Voyager Therapeutics)|NMRA - Company Assets|Scilex - Cumulative Company Assets|Aggregate Asset Value TVGN|ACOG - Aggregate Company Assets|CGTX (Cognition Therapeutics Inc.) - Total Business Assets|IKT: Company Total Assets|Company Assets cassavasciences.com (SAVA)|Cumulative Company Assets ASRT|Company Total Assets Coya|Aggregate Company Assets Vistagen Therapeutics (VTGN)|OVID (ovidrx.com) - Aggregate Asset Value|Aggregate Company Assets Acumen Pharmaceuticals ABOS|cervomed.com (CRVO) - Company Assets|ATHE - Aggregate Company Assets|Company Total Asset Base Clene Inc. CLNN|PEPG: Company Total Assets|Cumulative Company Assets Jupiter Neurosciences, Inc.|RLMD (Relmada Therapeutics) - Company Total Assets|annovisbio.com (ANVS) - Company Total Asset Base|Company Total Assets GRCE|KLTO - Company Assets|Aggregate Company Assets NeuroSense Therapeutics Ltd. NRSN|RVPH: Total Business Assets|MetaVia, Inc. - Company Total Assets|neuraxis.com (NRXS) - Cumulative Company Assets|HSDT: Company Total Assets|Company Assets Passage Bio (PASG)|Cumulative Company Assets NEUP|NERV: Aggregate Asset Value|Company Total Assets ATHA|Company Total Asset Base addextherapeutics.com|Aggregate Company Assets Alzamend Neuro ALZN|CYCN: Total Business Assets|Protagenic - Company Total Assets|Pasithea Therapeutics (KTTA) - Cumulative Company Assets|CRGT: Company Total Assets|avenuetx.com (ATXI) - Company Total Assets|BCLI (BrainStorm Cell Therapeutics) - Company Total Assets|Cara Therapeutics Inc. (CARA) - Company Total Asset Base|Company Total Assets CHRO|ELYM: Total Asset Value of Company|Company Total Assets ITCI (Intra-Cellular Therapies, Inc.)|LBPH (longboardpharma.com) - Total Asset Value of Company|MRNS - Aggregate Company Assets|NKGN (NKGen Biotech Inc) - Total Business Assets|NRBO: Company Total Assets|Company Assets Sage Therapeutics Inc (SAGE)|Cumulative Company Assets SNPX|Company Total Assets trevena.com|Aggregate Company Assets Vigil Neuroscience (VIGL)|WENA (anewmeds.com) - Aggregate Asset Value|Aggregate Company Assets Cerevel CERE